ArticleHormones (Athens, Greece)2025
Hypertensive retinopathy as the first manifestation of extra-adrenal paraganglioma.
Article in Hormones (Athens, Greece), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Parathyroid disease, gut microbiome, biologic age, and more.Hormones (Athens, Greece) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Paragangliomas are rare neuroendocrine tumors originating from paraganglionic cells in the autonomic nervous system and which are capable of secreting catecholamines and causing hypertensive crises. Although typically benign, they can exhibit aggressive features and present with varied clinical manifestations depending on location and catecholamine activity. Herein, we report an unusual case of a 28-year-old male who initially presented with bilateral grade IV hypertensive retinopathy, an uncommon initial manifestation of paraganglioma. Fundus examination revealed severe hypertensive retinopathy with exudative retinal detachment. Laboratory evaluation demonstrated markedly elevated plasma and urinary catecholamines and metanephrines. Imaging, including computed tomography (CT) and iodine-123 metaiodobenzylguanidine (MIBG) scintigraphy, confirmed a highly vascularized mass near the left adrenal gland, consistent with extra-adrenal paraganglioma. The patient's hypertension was medically stabilized prior to successful surgical tumor resection. Postoperatively, blood pressure normalized without medication, and significant improvement was observed in retinal findings, including resolution of disc edema and macular exudates. This case highlights the importance of considering paraganglioma in the differential diagnosis of malignant hypertension with ocular involvement, even when typical systemic symptoms of catecholamine excess are absent. Prompt recognition and intervention can lead to favorable visual and systemic outcomes.
Indexed as
Identifiers
40434715What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.